Gastrointestinal Cancer Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.
Featured
Niamh Coleman, MD, PhD, discusses data on whole exome sequencing (WES) of tumor tissue and ctDNA in GIST, presented at the AACR Annual Meeting.
View More
In part 1 of this video series, David Ilson, MD, PhD, reviews recent immunotherapy updates in GEJ/gastric cancer.
View More
In part 2 of this video series, David Ilson, MD, PhD, discusses approvals and advancements in the immunotherapy space for GEJ/GI cancer.
View More
In part 2 of this series, Andrea Cercek, MD, discusses the clinical findings, molecular drivers/alterations, and further research for "Early On-Set Colorectal Cancer: A Biologically Distinct Threat…
View More
In part 1 of this video series, Andrea Cercek, MD, discusses the background and possible association of hereditary/environmental factors in early-onset CRC.
View More
Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan, discusses trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer, an approval based on results…
View More
William Harris, MD, discusses a feasibility study on using biospecimen-based multi-platform profiling for patients with resected biliary tract cancer.
View More
Adam Diehl, MD, discusses an ongoing study assessing the ability to obtain NGS, ctDNA monitoring, and organoid drug sensitivity screening in patients with resected localized biliary tract cancer.
View More
Gentry King, MD, discusses an ongoing feasibility study on multiomic platform‑based testing in patients with localized and resectable biliary tract cancers.
View More
Stay in the know.
OncNet Newsletter